Oral sex has emerged as the leading risk factor for throat cancer, overtaking smoking and alcohol, according to recent medical studies. The rise is linked to human papillomavirus infections, which are increasingly driving oropharyngeal cancer cases worldwide.
While global attention has focused on cervical cancer prevention, experts warn that HPV-related throat cancers remain underreported. In the United States, HPV now accounts for more than 60 percent of oropharyngeal cancers, with men disproportionately affected. Declining tobacco use has shifted the burden toward sexually transmitted infections, yet public awareness of oral HPV transmission remains limited.
Vaccination programs, initially designed to protect girls from cervical cancer, have left boys vulnerable. In Kenya and other African nations, campaigns have largely excluded boys, raising concerns about future cancer rates. Unequal access and vaccine hesitancy further complicate prevention efforts, with coverage still below the levels needed for herd immunity.
Health specialists emphasize that expanding vaccination to boys and improving awareness about oral HPV transmission are critical steps. Without stronger policies and education, the silent epidemic of HPV-driven throat cancer may continue to grow unchecked, reshaping cancer prevention strategies for decades to come.
